COVID-Impfung als Booster für die Checkpointblockade: Besseres Gesamtüberleben beim malignen Melanom

Deutsche Dermatologie 2026

View at publisher

Authors: Friederike Klein

DOI: 10.1007/s15011-026-7253-9

Cited by: 0

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Cutaneous Melanoma Detection and Management COVID-19 and healthcare impacts